Results 261 to 270 of about 1,148,410 (327)
Some of the next articles are maybe not open access.
Patents, Pharmaceutical Industry and Healthcare
Pharmaceutical Patent Analyst, 2023[Abstract Not Available]
Ruqaiyyah Siddiqui, Naveed A Khan
openaire +3 more sources
Patenting Pharmaceuticals in China
Pharmaceutical Patent Analyst, 2016The pharmaceutical industry is developing fast in China and the market is getting more mature in recent years, which draws the attention of multinational producers and investors. Patent protection is important for the commercialization of pharmaceuticals in China.
Weiwei, Han, Juhua, Luo
openaire +2 more sources
SSRN Electronic Journal, 2012
India is known as the global pharmaceutical capital because of the ever growing generic drug manufacturing industry. With the growth of such an industry the issue of protection to pharmaceutical patents is also gaining importance. Pharmaceutical patent protection is of prime importance to pharma companies because of the huge amount of money invested in
M. Chatterjee
semanticscholar +2 more sources
India is known as the global pharmaceutical capital because of the ever growing generic drug manufacturing industry. With the growth of such an industry the issue of protection to pharmaceutical patents is also gaining importance. Pharmaceutical patent protection is of prime importance to pharma companies because of the huge amount of money invested in
M. Chatterjee
semanticscholar +2 more sources
Problem pharmaceutical patents
World Patent Information, 1996Abstract These days, the number of pharmaceutical patent applications which do not specify the principal active ingredient in the form of a chemical name or structure is increasing. These patents are difficult to retrieve in retrospective on-line searches using chemical structures or keywords.
Masaharu Kubo, Yukinori Itoh
openaire +1 more source
Gene Patents—A Pharmaceutical Perspective
Cambridge Quarterly of Healthcare Ethics, 1998The decade-long debate over ownership of living human materials has recently intensified with the ability of biomedical research to isolate, purify, and use human genes and gene products as therapeutics, factories for the production of therapeutics, and targets for the identification of therapeutic pharmaceuticals.
openaire +2 more sources
Patent citation analysis of Allergan pharmaceutical patents
Expert Opinion on Therapeutic Patents, 1998This is the second in a series of articles that apply patent citation analysis techniques to pharmaceutical patents. Co-citation clustering was used to identify the core pharmaceutical technological competencies of Allergan, Inc. and the technology fronts that this company is advancing.
Mary Ellen Mogee, Richard G Kolar
openaire +1 more source
Pharmaceutical patents and price controls
Clinical Therapeutics, 2002Since 1995, every member-country of the World Trade Organization (WTO) has agreed to honor a 20-year patent-life, from the date of a pharmaceutical company's application for the patent, in the country of application. Patent protection retards competitive imitation of an invented product.
openaire +2 more sources
Pharmaceutical Patents: Incentives for R&D or Marketing?
Social Science Research Network, 2008We analyse how a patent-holding pharmaceutical firm may strategically use advertising of existing drugs to affect R&D investments in new (differentiated) drugs, and thereby affect the probability distribution of future market structures in the industry ...
Kurt R. Brekke +3 more
semanticscholar +1 more source
Pharmaceutical Patents and Healthcare
Socio-Legal Review, 2006An essay on how the post-T.R.I.P.S.
openaire +1 more source
Drafting Pharmaceutical Patents
2011Abstract This chapter surveys the drafting of pharmaceutical patents across Australia, Canada, China, India, Japan, the United States, and Europe, explaining jurisdiction-specific practices and legal frameworks. It defines patentable subject matter, outlines permissible claim types, and prescribes requirements for pharmaceutical ...
openaire +1 more source

